Testing effectiveness (Phase 2)Ended earlyNCT00249002
What this trial is testing
Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis
Who this might be right for
Hemodialysis Graft Dysfunction
Celgene 9